.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

PULMICORT Drug Profile

« Back to Dashboard
Pulmicort is a drug marketed by Astrazeneca and Astrazeneca Pharms and is included in three NDAs. There are seven patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in PULMICORT is budesonide. There are nineteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the budesonide profile page.

Summary for Tradename: PULMICORT

Patents:7
Applicants:2
NDAs:3
Drug Prices: :see details
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
PULMICORT
budesonide
POWDER, METERED;INHALATION020441-002Jun 24, 1997DISCNNo► subscribe► subscribe
Astrazeneca Pharms
PULMICORT RESPULES
budesonide
SUSPENSION;INHALATION020929-003Aug 8, 2000RXYes6,899,099*PED► subscribeY► subscribe
Astrazeneca
PULMICORT FLEXHALER
budesonide
POWDER, METERED;INHALATION021949-002Jul 12, 2006RXYes6,027,714► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PULMICORT

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
PULMICORT
budesonide
POWDER, METERED;INHALATION020441-002Jun 24, 19974,524,769► subscribe
Astrazeneca
PULMICORT
budesonide
POWDER, METERED;INHALATION020441-003Jun 24, 19974,524,769► subscribe
Astrazeneca
PULMICORT
budesonide
POWDER, METERED;INHALATION020441-003Jun 24, 19974,907,583*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: PULMICORT

Drugname Dosage Strength RLD Submissiondate
budesonideInhalation Suspension1 mg/2 mLPulmicort Respules5/28/2010
budesonideInhalation Suspension0.25 mg/2 mL and 0.5 mg/2 mLPulmicort Respules9/15/2005
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc